Evidence map›Paper›PMID 19026341›Full record

ReviewClinics in perinatology2008

Inhaled nitric oxide and neuroprotection in preterm infants.

Jeremy D Marks, Michael D Schreiber

Open access · greenAbstract readReview
In one paragraph

Review in Clinics in perinatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeremy D MarksDepartment of Pediatrics, University of Chicago, Chicago, IL 60637, USA. jmarks@uchicago.edu
Michael D Schreiber
University of Chicago · US

Funding

Mechanisms of Co-Polymer-Mediated NeuroprotectionR01NS056313 · NINDS · UNIVERSITY OF CHICAGO · PI MARKS, JEREMY D · 2007 to 2011
$1.8M
NINDS NIH HHS NS056313NINDS NIH HHS R01 NS056313
6 · The paper itself

Abstract

Although inhaled nitric oxide-mediated decreases in chronic lung disease and severe intraventricular hemorrhage/periventricular leukomalacia undoubtedly contribute to improved neurodevelopmental outcomes, inhaled nitric oxide has an independent neuroprotective effect. Although these data are encouraging, additional studies are required before recommending the routine use of inhaled nitric oxide for neuroprotection in preterm infants.

Indexed as

Infant, PrematureAdministration, InhalationCentral Nervous System DiseasesHeartHumansInfant, NewbornLungNervous SystemNeuroprotective AgentsNitric OxideNeuroprotective AgentsNitric Oxide

Identifiers

PMID19026341
PMCPMC2717747
OpenAlexW2119819692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.